ABIONYX Pharma SA (EPA: ABNX)
France
· Delayed Price · Currency is EUR 1.344
-0.006 (-0.45%)
Dec 2, 2024, 9:11 AM CET
ABIONYX Pharma Revenue
ABIONYX Pharma had revenue of 2.34M EUR in the half year ending June 30, 2024, a decrease of -10.87%. This brings the company's revenue in the last twelve months to 4.86M, up 2.23% year-over-year. In the year 2023, ABIONYX Pharma had annual revenue of 4.64M, down -11.65%.
Revenue (ttm)
4.86M
Revenue Growth
+2.23%
P/S Ratio
8.24
Revenue / Employee
79.61K
Employees
61
Market Cap
44.25M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |